Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Elmiron Lawsuit Updates – January 2023

2 min read

Elmiron, the brand name of Pentosan with the active ingredient sodium pentosan polysulfate (PPS), is a commonly used drug to treat interstitial cystitis, also known as “painful bladder syndrome.” Elmiron is manufactured by Johnson & Johnson and gained FDA approval in the mid-1990s. Since then, it has been prescribed by doctors and used by patients throughout the United States to treat IC. Several medical studies were published beginning in 2018 linking the use of Elmiron with vision problems, specifically pigmentary maculopathy. In fact, some studies conclude that 54% of patients who took Elmiron later developed eye disease. Several product liability lawsuits were filed beginning in June 2020, claiming that Janssen Pharmaceuticals (Johnson & Johnson’s parent company) knew about the risks of eye disease while taking Elmiron and failed to warn the public. Here are the latest updates about the current mass tort lawsuit against Elmiron.

Elmiron Availability

Elmiron is the only FDA-approved oral drug to treat patients with interstitial cystitis. The drug was approved by the FDA in 1996 and has been widely available for treatment since then. Elmiron packaging and labels did not include a warning about potential eye damage until June 2020. Due to this, many patients continued to take Elmiron even after developing symptoms of pigmentary maculopathy or other vision changes. In addition, the FDA has not recalled the drug, so patients may not understand the dangers of taking it. If caught early, it is possible to stop further eye damage if the patient stops taking Elmiron. However, the lack of warning labels caused thousands of patients to continue taking the medication even as their vision deteriorated. In addition, symptoms were sometimes written off as a sign of aging, so the connection between Elmiron and eye disease was not made.

Case Count Increase

Janssen Pharmaceuticals currently faces 1,784 cases against Elmiron in federal court as of October 2022. This number continues to grow as more people who suffered eye damage caused by Elmiron come forward and file suit against the company.

Multidistrict Litigation Trial Delayed

A Multidistrict Litigation case (MDL) was filed in December 2020 with District Judge Brian R. Martinotti of New Jersey presiding. During MDLs, cases with similar complaints and evidence are combined and appear before one federal court. The New Jersey MDL was the first scheduled trial to take place regarding Elmiron, with Maria Windham as the plaintiff. Windham is a woman from Louisiana who suffered eye damage about two years after taking Elmiron. This case was scheduled to begin in January 2023. However, Judge Martinotti postponed the trial start date to March 27, 2023. The outcome of this trial will set the stage for all other cases against Elmiron and could indicate the terms of a global settlement.

Compensation for Vision Problems Caused by Elmiron 

If you have experienced retinal maculopathy or other vision problems after being prescribed Elmiron, you may be eligible to file a suit against Janssen Pharmaceuticals and receive damages for your injuries and other expenses. Contact the Michael Brady Lynch Firm at 888-585-5907 for a free consultation. You pay nothing unless you are given compensation through a verdict or settlement. For more information about Elmiron and vision problems, click here.

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta was marketed as a revolutionary drug to help people suffering from sickle cell disease manage their most painful symptoms. Oxbryta was manufactured by Global Blood Therapeutics (which was later bought by Pfizer) and approved by the FDA in 2019 for children and adults 12 years old and older. It was approved for children four years old and up in 2021. Alarming results from post-launch trials showed that Oxbryta may increase the symptoms of sickle cell disease instead of decreasing them.

read more
Mass Tort Abuses in the Mormon Church: A Legal Perspective

Mass Tort Abuses in the Mormon Church: A Legal Perspective

In recent years, the Church of Jesus Christ of Latter-day Saints (LDS), commonly known as the Mormon Church, has faced increasing legal scrutiny due to allegations of widespread abuse and institutional cover-ups. have come forward with claims of sexual, emotional, and physical abuse, many of which involve church leaders or institutions. These lawsuits have begun to take the form of mass tort claims, as multiple plaintiffs allege a systemic pattern of negligence and concealment within the organization.

read more
Understanding Copyright Law for OnlyFans Creators

Understanding Copyright Law for OnlyFans Creators

OnlyFans has become a booming platform for influencers and content creators, allowing them to monetize their work directly through subscriptions. However, with the rise of digital content creation comes the inevitable challenge of copyright infringement. Many OnlyFans creators find their exclusive content stolen and redistributed on unaffiliated websites without their permission. If you’re an OnlyFans influencer facing this issue, you may have legal recourse to protect your rights.

read more
Update on The New Maryland Child Sexual Abuse Law

Update on The New Maryland Child Sexual Abuse Law

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

read more
PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
×
What Our Clients Are Saying